Back to search results

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Abroad (travel likely)RecruitingPHASE2

Conditions

Diabetic Peripheral Neuropathic Pain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cullman Clinical Trials, Cullman, Alabama, United States

  • Trovare Clinical Research - Bakersfield CA, Bakersfield, California, United States

  • Eximia Research - San Diego, La Mesa, California, United States

  • Paradigm Clincial Research Centers, LLC., Wheat Ridge, Wheat Ridge, Colorado, United States

  • Accel Research - Deland, DeLand, Florida, United States

  • AMR Fort Myers (The Clinical Study Center), Fort Myers, Florida, United States

  • Velocity Clinical Research - Hallandale Beach, Hallandale, Florida, United States

  • Health Awareness, Inc., Jupiter, Jupiter, Florida, United States

  • Suncoast Research Associates - Miami, Miami, Florida, United States

  • Innovation Medical Research Center - Palmetto, Palmetto Bay, Florida, United States

  • Health Awareness, Inc. - Port St. Lucie, Port Saint Lucie, Florida, United States

  • Atlanta Center for Medical Research, Atlanta, Georgia, United States

  • Accel Research - Decatur, Decatur, Georgia, United States

  • Velocity Clinical Research - Boise, Meridian, Idaho, United States

  • Healthcare Research Network - Flossmoor IL, Flossmoor, Illinois, United States

  • Quest Research Institute, Farmington Hills, Michigan, United States

  • Healthcare Research Network - Hazelwood MO, Hazelwood, Missouri, United States

  • Eximia Research - Raleigh, Raleigh, North Carolina, United States

  • Velocity Clinical Research - Cleveland, Beachwood, Ohio, United States

  • Velocity Clinical Research - Providence, East Greenwich, Rhode Island, United States

  • Clinical Trials of South Carolina - Berkeley - Moncks Corner, Moncks Corner, South Carolina, United States

  • Gadolin Research, Beaumont, Texas, United States

  • Velocity Clinical Research, Dallas, Dallas, Texas, United States

  • San Antonio Clinical Trials, San Antonio, Texas, United States

  • AMR Norfolk, Norfolk, Virginia, United States

  • Centricity Research Brampton, Brampton, Canada

  • OCT Research ULC, Kelowna, Canada

  • Altasciences - Beaumont Clinic Montreal, Montreal, Canada

  • Mount Sinai Hospital - Leadership Sinai Centre for Diabetes (LSCD), Toronto, Canada

  • Centre Hospitalier Universitaire de Clermont-Ferrand - Site Gabriel-Montpied, Clermont-Ferrand, France

  • CHU de Nîmes - Pain Assessment and Treatment Center, Nîmes, France

  • Hopital Cochin - Rheumatology, Paris, France

  • North Hospital, Saint-Priest-en-Jarez, France

  • Ruhr-Universitaet Bochum - Heart and Diabetes Center, Bad Oeynhausen, Germany

  • FutureMeds GmbH, Berlin, Germany

  • FutureMeds Frankfurt, Offenbach/Main, Germany

  • Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

  • IRCCS Ospedale San Raffaele - InSpe and Division of Neuroscience, Milan, Italy

  • Birmingham Heartlands Hospital - Heartlands Hospital Diabetes Centre and MIDRU, Birmingham, United Kingdom

  • FutureMeds Birmingham, Birmingham, United Kingdom

  • Ninewells Hospital - Endocrinology, Dundee, United Kingdom

  • FutureMeds Glasgow, Glasgow, United Kingdom

  • University of Liverpool - Aintree University Hospital, Liverpool, United Kingdom

  • St Pancras Clinical Research, London, United Kingdom

  • Manchester Diabetes Centre (MDC), Manchester, United Kingdom

  • George Eliot Hospital NHS Trust, Nuneaton, United Kingdom

  • Royal Hallamshire Hospital - Endocrinology, Sheffield, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)